The Biotech Casino Strikes Again As ARCA Biopharma Inc Surges 230%

Looking for a kick arse rate of return today? Well it’s too late to hop on the gravy train known as ARCA biopharma Inc (ABIO).

The stock is up 230% after the US Patent Office approved an ARCA patent attributed to treating heart failure.

ABIO 220 per cent

Photo: FinViz

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at